NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S
The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Tuesday, 21 January 2025 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, 6823 Ansager, Denmark The agenda for the extraordinary general meeting is as follows: Proposed resolution to change the nominal value of the shares of the 1. Company by way of a reverse share split (proposed by the board of directors) Pursuant to art. 12.20 of the Company’s articles of association, the Board of Directors appoints